Myeloma


Myeloma, commonly referred to as multiple myeloma, is a blood cancer that develops from plasma cells. It can be benign or malignant. In the UK, there are approximately 17,500 myeloma patients at any given moment. It is responsible for 2% of all malignancies and 15% of blood cancers. Myeloma primarily affects those over 65, but it has been identified in those as young as 20.


  • Multiple Myeloma
  • Signal Transduction
  • Metastatic Cancer
  • Hematologic Cancer
  • Signaling Pathway
  • Information on Drugs
  • Medicine for Inflammation

Related Conference of Myeloma

February 24-25, 2025

4th European Congress on Hematology

Madrid, Spain
July 07-08, 2025

23rd World Hematology Congress

Zurich, Switzerland

Myeloma Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in